Effect of Spironolactone on Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction: Post-Hoc Analysis of the Randomized, Placebo-Controlled TOPCAT Trial.
Jolien NeefsNicoline W E van den BergSébastien P J KrulS Matthijs BoekholdtJoris R de GrootPublished in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2020)
ClinicalTrials.gov identifier no. NCT00094302 (TOPCAT).
Keyphrases
- placebo controlled
- phase iii
- double blind
- phase ii
- atrial fibrillation
- study protocol
- clinical trial
- open label
- catheter ablation
- left atrial
- oral anticoagulants
- phase ii study
- left atrial appendage
- heart failure
- randomized controlled trial
- direct oral anticoagulants
- percutaneous coronary intervention
- squamous cell carcinoma
- acute coronary syndrome
- left ventricular
- rectal cancer